Fortress Biotech, Inc 10-Q for FY2026 Q1
Fortress Biotech, Inc. (FBIO)
10-Q
2026-05-14
For: 2026-03-31
View Original
Added on
May 15, 2026
About this 10-Q
Fortress Biotech, Inc filed this 10-Q on May 14, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).
Headline figures
Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $16.04M
- up 22.1% from $13.14M a year earlier
- Net income
- $110.37M
- compared with a net loss of $10.58M a year earlier
- Diluted EPS
- $2.82
- compared with -$0.48 a year earlier